rs761555167
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000487.6(ARSA):c.1344dupC(p.Gly449ArgfsTer124) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,612,174 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000487.6 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARSA | NM_000487.6 | c.1344dupC | p.Gly449ArgfsTer124 | frameshift_variant | Exon 8 of 8 | ENST00000216124.10 | NP_000478.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARSA | ENST00000216124.10 | c.1344dupC | p.Gly449ArgfsTer124 | frameshift_variant | Exon 8 of 8 | 1 | NM_000487.6 | ENSP00000216124.5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 249430Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135324
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1459970Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726172
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74356
ClinVar
Submissions by phenotype
Metachromatic leukodystrophy Pathogenic:4
- -
Variant summary: ARSA c.1344dupC (p.Gly449ArgfsX124) causes a frameshift which results in an extension of the protein. The variant allele was found at a frequency of 2e-05 in 249430 control chromosomes. c.1344dupC has been reported in the literature in individuals affected with Metachromatic Leukodystrophy (example, Wang_2007, Liaw_2015, Wang_2016, Li_2018). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
This sequence change results in a frameshift in the ARSA gene (p.Gly449Argfs*124). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 61 amino acid(s) of the ARSA protein and extend the protein by 62 additional amino acid residues. This variant is present in population databases (rs761555167, gnomAD 0.03%). This frameshift has been observed in individual(s) with metachromatic leukodystrophy (PMID: 17560502, 27374302). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as c.1338dupC. ClinVar contains an entry for this variant (Variation ID: 557962). This variant results in an extension of the ARSA protein. Other variant(s) that result in a similarly extended protein product (p.Arg498Profs*7) have been determined to be pathogenic (PMID: 19021637, 26462614). This suggests that these extensions are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at